Serum Cystatin C as an Inflammatory Marker in Exacerbated and Convalescent COPD Patients

Ming Zhang,Yali Li,Xia Yang,Hu Shan,Qiuhong Zhang,Zongjuan Ming,Yingying Xie,Haijuan Chen,Yanqin Liu,Jie Zhang
DOI: https://doi.org/10.1007/s10753-015-0287-x
2015-01-01
Inflammation
Abstract:Chronic obstructive pulmonary disease (COPD) is a common chronic inflammatory disease with high morbidity and mortality rates. Cystatin C (Cys C) is a sensitive indicator for various chronic inflammatory diseases. In this study, we aimed to evaluate the role of Cys C in COPD patients comparing with the other well-known inflammatory markers. Ninety patients with acute exacerbated COPD were studied and were reassessed when convalescent. Ninety controls were matched for age, gender, body mass index, smoking index, and comorbidity. Serum Cys C was significantly increased in convalescent COPD patients compared with healthy controls and further increased in COPD patients with an acute exacerbation. Serum Cys C was positively correlated with hsCRP both in the exacerbation and convalescence periods of COPD and negatively correlated with FEV 1 % predicted and FEV 1 /FVC in the convalescent COPD patients. In conclusion, serum Cys C is a positive acute-phase reactant in COPD patients and might indicate systemic inflammation during the progression of COPD.
What problem does this paper attempt to address?